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INTRODUCTION
Several neurological disease processes can cause changes 
in bladder and bowel function (Chancellor and Blaivas, 
1995; Skeill, 2001). Bladder and bowel problems cause 
much anxiety and may reduce quality of life (Chancellor 
and Blaivas, 1995).
Treatment procedures of neurological patients with gen-
itourinary and bowel problems are largely based on em-
pirical evidence with a limited research base (Chancellor 
and Blaivas, 1995; Harari et al., 2004; Leboeuf and Gousse, 
2004). An assessment of the patient’s physical, psychologi-
cal, cognitive and emotional limitations may influence 
the treatment strategy. Although many options exist for 
therapy, a stepwise approach with initially non-invasive 
treatment is important considering the course of the dis-
ease (Chancellor and Blaivas, 1995; Leboeuf and Gousse, 
2004). The role of pelvic floor physical therapy for blad-
der and bowel problems in specific neurological diseases 
is actually more and more investigated. Eleven random-
ized controlled studies of pelvic floor physical therapy 
for stroke (Tibaek et al., 2004, 2005, 2007) and MS pa-
tients (Vahtera et al., 1997; Prasad, 2003; McClurg, 2006, 
2008, 2010; Khan, 2010; Lucio, 2010, 2011) with bladder 
and bowel problems are published. Other neurological 
pathologies like Parkinson’s disease, spina bifida, syrin-
gomyelia, peripheral neuropathies, Huntington’s disease, 
multiple system atrophy, dementia, spinal cord injuries, 
disc prolapse and tumours of the spinal cord might also be 
responsible for the development of a neurogenic bladder 
and bowel dysfunctions. No randomized controlled trials 
on evidence for pelvic floor physical therapy in those neu-
rological diseases can be found, although physical therapy 
of the pelvic floor in Parkinson’s disease and spinal cord 
injury patients with partial lesion has been undertaken 
(Ishigooka et al., 1996; Vaughan et al., 2011).
This chapter is limited to treatment of stroke and MS 
patients with genitourinary and/or bowel problems.
STROKE
Definition
Stroke or cerebrovascular accident (CVA) is the clinical 
manifestation of ischemia or infarction of brain tissue 
caused by arterial occlusion, intracerebral and subarach-
noid haemorrhage or congenital malformation (Flisser 
and Blaivas, 2004).
Incidence and prevalence
Each year a typical health authority of 1000 men and 
women can expect two new stroke cases and four recurrent 
stroke patients and there will be approximately six survi-
vors of stroke living in the community (Chancellor and 
Blaivas, 1995).
Urologic and bowel symptoms  
and urodynamic investigation
Urinary incontinence (UI) was reported in 32–83% in the 
early period after stroke. A review of prevalence of inconti-
nence was given by Brittain et al. (1998). The natural  history 
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of UI following stroke knows a gradual, spontaneous im-
provement from 19% at 3 months, 15% at 1 year to 10% at 
2 years (Patel et al., 2001). Jorgensen et al. (2005) found a 
prevalence of 17% UI among long-term survivors and 7% of 
the control subjects without stroke. Sakakibara (1996) per-
formed micturitional histories and urodynamic investiga-
tion in 72 stroke patients. A total of 53% of the patients had 
one or more urinary symptoms within 3 months after stroke. 
Thirty-six per cent had nocturia followed by 29% with ur-
gency incontinence and 25% with difficulty of voiding. 
Urodynamic investigation shows that initially after stroke 
the bladder is often areflexic (Flisser and Blaivas, 2004). 
Detrusor hyperreflexia and urgency incontinence gener-
ally follow. Sphincteric incontinence in the recovery phase 
is normally not a consequence of the stroke but is almost 
always a premorbid condition (Flisser and Blaivas, 2004).
Anal incontinence in stroke patients was reported in 
23–40% of the cases on admission and 7–9% 6 months 
after stroke (Brocklehurst et al., 1985; Nakayama et al., 
1997; Brittain et al., 1998; Krogh et al., 2001).
Initial incontinence is associated with age older than 
75 years, visual field defect, dysphagia, motor weakness, sever-
ity of stroke, diabetes, hypertension and comorbidity of other 
diseases (Nakayama et al., 1997; Gross, 2000; Sze, 2000; Patel 
et al., 2001). Furthermore, UI in the acute stage is a predictor 
of survival and closely associated with disability severity (Patel 
et al., 2001). UI emerged as a risk factor for nursing home 
 replacement (Patel et al., 2001; Pettersen et al., 2002).
Pathophysiology
Not all incontinence after stroke is directly related to 
neurologic injury of the micturition pathways. Other 
mechanisms are general impairment, cognitive deficits 
and overflow incontinence unrelated to stroke (Flisser 
and Blaivas, 2004). The neurophysiologic explanation 
for detrusor areflexia in the initial phase after stroke is 
unknown. Detrusor-hyperreflexia was noted in lesions of 
the frontal lobe as well as the basal ganglia. Uninhibited 
sphincter relaxation is typical for frontal lobe lesions and 
detrusor sphincter dyssynergia are common in the basal 
ganglia lesions (Sakakibara et al., 1996). The location of 
the injury, the extent of the damage and the role of the af-
fected area determine the precise urologic impact (Flisser 
and Blaivas, 2004). Rationale for physical therapy after 
stroke can be explained because patients have problems of 
urgency, stress and urge incontinence. The aim of physical 
therapy is to strengthen or to relax the pelvic floor muscles 
and to reduce frequency, urgency and nocturia.
Treatment: evidence for effect 
(prevention and treatment)
There has been little research into treatment of urinary 
and faecal incontinence and constipation in stroke survi-
vors. Wikander et al. (1998) concluded that incontinence 
reduced significantly after a special multidisciplinary pro-
gramme in comparison with a control group treated with 
a conventional rehabilitation programme. The special 
multidisciplinary programme contained physical training 
(dressing, transfer in the hospital and at home with atten-
tion to bladder and bowel management), social and cogni-
tive interaction (memory training, problem solving, social 
interaction, expression and comprehension). Harari et al. 
(2004) concluded that a single clinical/educational nurse 
intervention in stroke patients effectively improved bowel 
dysfunctions up to 6 months later and bowel modifying 
lifestyle behaviours up to 12 months later.
The effect of pelvic floor muscle training on inconti-
nence in stroke patients was evaluated in three random-
ized controlled studies (Tibaek et al., 2004, 2005, 2007). 
In fact, this is one RCT of 26 incontinent women reported 
in two publications because two different assessment 
tools were used. A third study investigated the 6-month 
long-term effect of 24 of these women on quality of life 
(QoL) (Table 12.1). The effect of pelvic floor exercises in 
women with UI after stroke was measured by QoL param-
eters (Tibaek et al., 2004) and by diary for the frequency of 
voiding, incontinence episodes and number of pads, 24-
hour home pad-test and vaginal palpation of pelvic floor 
muscles (Tibaek et al., 2005). The intervention included 
groups treatment during 12 weeks comprising of 12–24 
standardized pelvic floor exercises. The control group fol-
lowed the normal standard programme of stroke rehabili-
tation without specific treatment of UI.
In the first study, QoL measured with the Short Form 36 
Health Survey Questionnaire (SF-36) and Incontinence 
Impact Questionnaire (IIQ-7) did not show significant differ-
ence between the two groups after 12 weeks (Tibaek, 2004).
In the second study, a significant improvement of 
frequency of voiding (p = 0.028), 24-hour home pad-
test (p = 0.013) and endurance of pelvic floor muscles 
(p = 0.028) was demonstrated in the treatment group com-
pared with the control group (Tibaek, 2005).
In the third study, QoL was measured with the Short 
Form 36 Health Survey Questionnaire (SF-36) and the 
Incontinence Impact Questionnaire (IIQ-7). A trend to 
a long-lasting effect regarding role limitations because 
of emotional problems (SF-36) and a tendency to a de-
creased impact of UI compared with the control group 
(IIQ-7) were found (Tibaek, 2007).
The methodological quality was 5 out of 10 on the Pedro 
scale; neither the patients nor the therapist or assessor were 
blind to the study (Table 12.2). Other limitations of the 
study are a small sample size, 12 women in each group. 
In the first study (Tibaek et al., 2004), the instruments to 
document the effect are not the optimal choice because 
the SF-36 gives an indication of general health and the IIQ 
turned out to be rather insensitive towards women with 
urge urinary incontinence. Remarkable is the fact that only 
8% of the 339 stroke patients were potential candidates 
for pelvic floor physical therapy, mostly because of their 
neurological status (Tibaek et al., 2004, 2005).
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Table 12.1  Randomized controlled studies of physical therapy for bladder and bowel dysfunctions  
in neurogenic patients
Stroke
Author Tibaek et al., 2004
Design 
 
2-arm RCT 
Experimental group (E): PFMT
Control group (C): no treatment for incontinence
n 26 women (E = 14, C = 12), mean age 60 years (range: 56–74) with stroke
Diagnosis Short Form 36 Health Survey Questionnaire (SF-36) and Incontinence Impact Questionnaire (IIQ-7
Training protocol 
 
 
 
E: PFMT 6 s contraction, 6 s rest, 3 s contraction, 3 s rest, 30 s contraction, 30 s rest; Every 
contraction: 4–8 times in different positions, group-treatment (6–8 patients) 1 h/week 
during 12 weeks outpatient; individual: vaginal palpation 2–3 times over 12 weeks
Home exercises: 1–2 times daily
C: no treatment for UI but normal standard programme for rehabilitation
Drop-out 8%
Results No significant difference between E and C group in SF-36 and IIQ-7
Author Tibaek et al., 2005
Design 
 
2-arm RCT 
Experimental group (E): PFMT
Control group (C): no treatment for incontinence
n 26 women (E = 14, C = 12), mean age 60 years (range: 56–74) with stroke
Diagnosis Voiding diary, UI 24-h pad-test, number of pads, digital palpation of pelvic floor muscles
Training protocol 
 
 
 
 
E: PFMT 6 s contraction, 6 s rest, 3 s contraction, 3 s rest, 30 s contraction, 30 s rest
Every contraction: 4–8 times in different positions; group-treatment (6–8 patients)  
1 h/week during 12 weeks outpatient; individual: vaginal palpation 2–3 times  
in 12 weeks
Home exercises: 1–2 times daily
C: no treatment for UI but normal standard programme for rehabilitation
Drop-out 8%
Results Significant difference between E and C group in frequency of voiding (p = 0.028), 24-h 
home pad-test (p = 0.013)and endurance of pelvic floor muscles (p = 0.028)
Author Tibaek et al., 2007
Design 
 
2-arm RCT 
Experimental group (E): PFMT
Control group (C): no treatment for incontinence
n 24 women (E = 12, C = 12), mean age 60 years (range: 56–74) with stroke
Diagnosis Short Form 36 Health Survey Questionnaire (SF-36) and Incontinence Impact  
Questionnaire (IIQ7) > 6 mth later
Training protocol Identical to Tibaek, 2004 and 2005
Drop-out /
Results No significant difference between E and C group in SF-36 and IIQ-7: only trend
MS
Author McClurg et al., 2006
Design 
 
3-arm RCT 
Control group (C): PFMT and advice
Experimental group (E): E1: + BF; E2: + BF + NMES
n 30 women with MS: C = 10, mean age 49 years; E1 = 10, mean age 52 years; E2 = 10, mean 
age 49 years (range: 33–67)
Diagnosis Leakages on voiding diary, 24-h pad-test, uroflowmetry, PF assessment (PERFECT scheme) 
and IIQ, UDI, KHQ, MSQoL. Assessment at week 0, 9, 16, 24
AU1
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t0010
To protect the rights of the author(s) and publisher we inform you that this PDF is an uncorrected proof for internal business use only by the author(s), editor(s),
reviewer(s), Elsevier and typesetter SPi. It is not allowed to publish this proof online or in print. This proof copy is the copyright property of the publisher and is
confidential until formal publication.
B978-0-7020-4443-4.00012-1, 00012
BO, 978-0-7020-4443-4
4
Comp. by: KARajakumari Stage: Proof Chapter No.: 12 Title Name: BO
Page Number: 4 Date: 31/05/2014 Time: 05:29:00
Evidence-Based Physical Therapy for the Pelvic Floor
Table 12.1  Randomized controlled studies of physical therapy for bladder and bowel dysfunctions  
in neurogenic patients—cont’d
Training protocol 
 
 
Treatment during 9 weeks
C: advice + PFMT gradually, 5 times a day; E1: + BF, E2: + BF + NMES 
ES = biphasic CC, two parameter settings 
250 μs, 40 Hz, 5 s on, 10 s off/ 450 μs, 10 Hz, 10 s on, 3 s off; duration from 5 to 30 minutes daily
Drop-out 2/30
Results 
 
 
Significant difference in favour of E2 compared with C at 9, 16 and 24 weeks for leakages, 
24-h pad-test, digital assessment en in some parts of the questionnaires (p <0.05)
Significant difference in favour of E1 compared with C for leakages, 24-h pad-test, digital 
assessment in some parts of the questionnaires (p <0.05) at 16 and 24 weeks
Author McClurg et al., 2008
Design 
 
2-arm RCT 
C: PFMT, BF and placebo ES
E: PFMT, BF and ES
n 74 women with MS: C = 37, mean age 52 years; E = 37, mean age 48 years (range: 27–72)
Diagnosis Leakages on voiding diary, 24-h pad-test, uroflowmetry, PF assessment (PERFECT scheme), 
EMG, VAS, IIQ, UDI, IPSS
Assessment at week 0, 9, 16, 24
Training protocol 
 
 
 
Treatment during 9 weeks
PFMT, BF and ES 
ES = biphasic CC 
Two parameter settings: 250 μs, 40 Hz, 5 s on, 10s off/ 450 μsec, 10 Hz, 10 s on, 3 s off; 
duration from 5 to 30 min daily
Drop-out 2/74
Results” Significant difference in favour of E compared with C for leakages, 24-h pad-test, digital 
assessment and some parts of the questionnaires
Author McClurg et al., 2010
Design 
 
2-arm RCT 
E: Advice + abdominal massage
C: Advice
n 30 women with MS and constipation; E = mean age 52 years; C = 37, mean age 48 years 
(range: 27–72)
Diagnosis CSS, neurogenic bowel dysfunction, bowel diary
Assessment at week 0, 4, 8
Training protocol Advice on bowel management
Abdominal massage daily for 4 weeks
Drop-out 1/30
Results Significant difference in favour of E compared with C for constipation symptoms (p = 0.003)
Author Khan et al., 2010
Design 
 
2-arm RCT 
Experimental group (E): bladder rehabilitation programme
C: control group: no
n 74 women with MS; E = 40, mean age 49 years; C = 34, mean age 51 years (range: 29–65)
Diagnosis Questionnaires: UDI-16, NDS, AUA, IIQ-7
Training protocol 
 
 
 
E: multidisciplinary bladder rehabilitation programme during 1 year: or individualized 
inpatient (IP) or outpatient (OP) programme
IP = 3 h/day over 6 weeks, OP = 30 min 2–3x/week
Therapy: individual, assessment of bladder type, diary with strict fluid, PFME, timed voiding
C: waitlist group with usual care
Drop-out 22%
Results Significant difference between E and C group in all questionnaires (p <0,01), improvement 
in bladder function, overactivity and QoL
AU2
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Author Lucio et al., 2010
Design 
 
2-arm RCT 
Experimental group (E): PFMT
Control group (C): sham treatment for LUTS
n 27 women with MS: E = 13, mean age 36 years; C = 14, mean age 34.7 years (range: 20–49)
Diagnosis Urodynamics, 24-h pad-test, voiding diary, PF assessment (PERFECT scheme)
Training protocol 
 
 
E: PFME with perineometer: 30 slow contractions, 3 min of fast contractions in supine position
Treatment: 30 min, 2 times/week for 12 weeks outpatient
Home exercises: 3 times daily 30 slow contractions, 3 min of fast contractions
C: introduction of perineometer inside the vagina without contraction during 30 min
Drop-out Not reported
Results 
 
Significant difference between E and C group in 24-h pad-test (p = 0.00), number of pads 
(p = 0.01), nocturia (p <0.00) and improvement of pelvic floor muscle power, endurance, 
resistance and fast contractions (p < 0.00) No significant difference in urodynamics
Author Lucio et al., 2011
Design 
 
2-arm RCT 
Experimental group (E): PFMT
Control group (C): sham treatment for LUTS
n 35 women with MS: E = 18, mean age 36 years; C =17, mean age 34.7 years (range: 20–49)
Diagnosis OAB questionnaire, Medical outcomes study, ICIQ, Qualiveen questionnaire
Training protocol 
 
 
E: PFME with perineometer: 30 slow contractions, 3 min of fast contractions in supine position
Treatment: 30 min, 2 times/week for 12 weeks outpatient 
Home exercises: 3 times daily 30 slow contractions, 3 minutes of fast contractions
C: introduction of perineometer inside the vagina without contraction during 30 min
Drop-out Not reported
Results Significant difference between E and C group in all questionnaires
Author Prasad et al., 2003
Design 
 
3-arm RCT
Treatment (T): T1 = lower abdominal pressure, T2 = bladder stimulation
C = no T for post-void RV
n 
 
18 women and 10 men with MS and post-void RV
Mean age 49 years (range: 29–71)
All patients follow all treatments
Diagnosis Post-void RV
Training protocol 
 
T1 = lower abdominal pressure (Crede’s manoeuvre) during 2 weeks
T2 = bladder stimulation with bladder stimulator during 2 weeks; 1 minute after voiding
C = no T during 2 weeks
Drop-out 2/30 after randomization
Results 
 
No significant difference between T1 and T2 group but results reach significance in favour 
of vibration (p = 0.059) 
Significant difference between T2 and C group in RV (p = 0.002)
Author Vahtera et al., 1997
Design 
 
2-arm RCT 
Experimental group (E): PFMT and ES
Control group (C): no treatment for LUTD
n 50 women and 30 men with MS (E = 40, C = 40); mean age 43 years (range: 25–68)
Diagnosis LUTS by self-administered questionnaire, muscle activity by surface EMG-BF
 (Continued)
Table 12.1  Randomized controlled studies of physical therapy for bladder and bowel dysfunctions  
in neurogenic patients—cont’d
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Table 12.2  PEDro quality score of RCTs in systematic review of pelvic floor physical therapy for neurological diseases
 E – Eligibility criteria specified
 1 – Subjects randomly allocated to groups
 2 – Allocation concealed
 3 – Groups similar at baseline
 4 – Subjects blinded
 5 – Therapist administering treatment blinded
 6 – Assessors blinded
 7 – Measures of key outcomes obtained from >85% of subjects
 8 – Data analysed by intention to treat
 9 – Statistical comparison between groups conducted
10 – Point measures and measures of variability provided
Study E 1 2 3 4 5 6 7 8 9 10 Total score
McClurg, 2006 + + – + – – – + + + + 6/10
McClurg, 2008 + + + + + – + + + + + 9/10
McClurg, 2010 + + – + – – + + – + + 6/10
Khan, 2010 + + + + – – – + + + + 7/10
Lucio, 2010 – + – + – – + + – + + 6/10
Lucio, 2011 – + – + – – + + – + + 6/10
Prasad, 2003 + – – – – – + – + + + 4/10
Tibaek, 2004 + + – + ? – – + – + + 5/10
Tibaek, 2005 + + – + ? – – + – + + 5/10
Tibaek, 2007 + + – + – – + – – + + 5/10
Vahtera, 1997 + + – + – – – – – + + 4/10
+, criterion is clearly satisfied; −, criterion is not satisfied; ?, not clear if the criterion was satisfied. Total score is determined by counting the 
number of criteria that are satisfied, except that ‘eligibility criteria specified’ score is not used to generate the total score. Total scores are out of 10.
Table 12.1  Randomized controlled studies of physical therapy for bladder and bowel dysfunctions  
in neurogenic patients—cont’d
Training protocol 
 
 
 
 
 
E: PFMT: 3 s contraction, 3 s rest (10 times) 5 s contraction, 3 s rest (5 times) 15 s contraction, 
30 s rest (5 times), others: 5 times in different positions
ES: interferential currents carrier frequency of 2000 Hz treatment frequency of 5–10 Hz, 
10–50 Hz and 50  Hz, 10 min of each frequency, 3 min rest, 6 sessions during 21 days outpatient 
BF: same PFMT after ES during 2 sessions; home exercises: 20 contractions 3–5 times/week 
during 6 mth in sitting and standing position
C: no treatment
Drop-out At 2 mth 2/40, at 6 mth 3/40 in the E group, not mentioned in control group
Results Significant difference between E and C group in LUTS (incontinence, nocturia, urge)  
p <0.001, QoL (travelling, social shame and need of pads) muscle activity p <0.01.
KHQ, Kings Health Questionnaire; UDI, <stands for?>; CC <stands for?>; VAS, visual analogue score; IPSS, International Prostate Symptom  
Score; CSS, <stands for?>, NDS, <stands for?>; AUA, American Urological Association; ICIQ, International Consultation on Incontinence 
Questionnaire; RV, residual volume. For other abbreviations, see text.
AU3
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Conclusions and clinical 
recommendations
Clinical recommendations based on to-date evidence pro-
mote pelvic floor exercises to reduce incontinence with 
special attention to education and improvement of physi-
cal functions and social interaction but conclusions have 
to be drawn cautiously because of limited research (Tibaek 
et al., 2004, 2005, 2007).
MULTIPLE SCLEROSIS (MS)
Definition
MS is caused by inflammatory and demyelinating lesions 
in the white matter of the brain and the spinal cord, lead-
ing to a wide variety of neurological deficits (Chancellor 
and Blaivas, 1995).
Incidence and prevalence
The disease has an incidence of approximately 1 new 
case per 10 000 people every year, mostly manifesting be-
tween the ages of 20 and 50 years. MS is more common 
in women than in men by a ratio of 2:1. The prevalence 
is about 1 per 1000 in the United States and 2 per 1000 in 
North Europe. MS is less common in Orientals (Leboeuf 
and Gousse, 2004).
Urologic and bowel symptoms
Urologic symptoms in MS patients vary greatly from 
one study to another. Urgency, reported in 24–86% of 
the cases, and frequency, between 17% and 82% are 
the most frequent symptoms in the MS population 
(Mayo and Cchetner, 1992; Leboeuf and Gousse, 2004). 
Urgency incontinence is reported in 19 to 72% while hes-
itancy and retention is found in 2 to 49% of MS patients 
(Leboeuf and Gousse, 2004; Mayo and Chetner, 1992). 
Constipation was found in 54% of the MS patients 
while 29% experienced faecal incontinence (Hennessey 
et al., 1999). All these symptoms are rated as the third 
most important problem in MS after spasticity and in-
coordination, limiting patients’ ability to work (Jawad 
et al., 1999). In men and women with MS not all the 
urologic dysfunctions can be presumed to be secondary 
to MS. A poor correlation has been found between sub-
jective symptoms and objective urodynamic evaluations 
(Chancellor and Blaivas, 1995).
Pathophysiology
Damage to the innervation of the lower urinary tract 
mostly affects the sphincter and the detrusor. Three 
main types of pattern of urodynamic dysfunction are 
described:
• detrusor hyperreflexia without bladder outlet 
obstruction will occur in 26–99% of MS patients;
• detrusor hyperreflexia with detrusor-external 
sphincter dyssynergia (DESD) is documented in 
23–52% of MS patients;
• MS patients with detrusor hypo- or areflexia are seen 
in 6–40% of the cases (Chancellor and Blaivas, 1995; 
Gallien et al., 1998; Leboeuf and Gousse, 2004).
Treatment: evidence for effect 
(prevention and treatment)
A few authors investigated physical therapy as a treatment 
modality in MS patients but without a control group (Van 
Poppel et al., 1985; Primus, 1992; Klarskov et al., 1994; De 
Ridder et al., 1999; Skeill et al., 2001) and noted a good sub-
jective improvement in incontinent episodes and pad use 
after electrical stimulation or biofeedback training. Primus 
(1992) gave maximal vaginal electrical stimulation on 27 MS 
patients and found an initial efficacy of 85% but a decrease 
during follow up to 18% after 3 months. They concluded 
that long-term treatment is necessary to minimize symp-
toms in the MS population. De Ridder et al. (1999) offered a 
practical tool in the selection of MS patients to predict good 
prognosis: pelvic floor physical therapy should be restricted 
to patients with mild MS, without pelvic floor spasticity or 
detrusor sphincter  dyssynergia. They designed a digital scor-
ing system for pelvic floor spasticity based on experience:
1 = spastic muscle unable to relax even after passive 
elongation;
2 = hypertonic muscle with temporary relaxation after 
elongation;
3 = active relaxation after active contraction.
This digital test has proven to be reliable between examin-
ers (r = 0.90).
Bowel management in MS patients is empirical with a lack 
of evidence. Only one study investigated the effect of physi-
cal therapy but without a control group. Wiesel et al. (2000) 
offered biofeedback training as treatment in 13 patients with 
MS complaining of constipation or faecal incontinence. 
Five patients experienced a beneficial effect of biofeedback. 
Treatment was more likely to be successful in patients with 
limited disability and a non-progressive disease course.
Evidence-based medicine on MS  
and pelvic floor physical therapy
Evidence-based medicine on pelvic floor physical therapy 
for MS was researched in eight studies (see Table 12.1).
Seven studies described the efficacy of physical therapy to 
reduce urgency, frequency, incontinence, nocturia and bladder emp-
tying. Vahtera et al. (1997) investigated the effect of  electrical 
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Clinical recommendations
Based on evidence to date, electrical stimulation and pelvic 
floor exercises in MS patients decreases urgency, frequency, 
incontinence, nocturia and improves bladder emptying 
and pelvic muscle activity. Abdominal massage is effective 
to reduce constipation. Further research will establish the 
efficacy of these interventions.
CONCLUSION
Conclusions and clinical recommendations on the role of 
pelvic floor physical therapy for genitourinary and bowel 
problems in specific neurological diseases as stroke have to be 
taken with care because of the lack of good  randomized con-
trolled trials with a sufficient number of patients. A significant 
improvement of incontinence in stroke patients was demon-
strated offering a 12-week PFME group treatment while QoL 
was the same for the experimental and control group.
For MS patients, a significant difference in lower urinary 
tract symptoms and pelvic floor muscle activity was found 
after electrical stimulation, biofeedback and pelvic floor 
muscle exercises or bladder training compared with a con-
trol group without specific treatment or with one modality 
of treatment. Abdominal massage has a positive effect on 
the symptoms of constipation.
The methodological quality of recent studies is high.
For patients with other neurological disorders, efficacy 
of physical therapy is not yet investigated.
Research on efficacy and selection criteria for pelvic floor 
physical therapy is necessary to help neurological patients to 
prevent urological and bowel complications and to improve 
quality of life. Future research has to be undertaken not only 
on stroke and MS but also on other neurological diseases.
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